মোল্দাভিয়া -
রোমানীয় -
AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)
pegintron pulbere si solvent pentru solutie injectabila 100 mcg/0,5 ml
merck sharp&dohme limited - peginterferon alfa-2b - pulbere si solvent pentru solutie injectabila - 100 mcg/0,5 ml
মোল্দাভিয়া -
রোমানীয় -
AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)
pegintron pulbere si solvent pentru solutie injectabila 120 mcg/0,5 ml
merck sharp&dohme limited - peginterferon alfa-2b - pulbere si solvent pentru solutie injectabila - 120 mcg/0,5 ml
মোল্দাভিয়া -
রোমানীয় -
AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)
pegintron pulbere si solvent pentru solutie injectabila 50 mcg/0,5 ml
merck sharp&dohme limited - peginterferon alfa-2b - pulbere si solvent pentru solutie injectabila - 50 mcg/0,5 ml
মোল্দাভিয়া -
রোমানীয় -
AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)
pegintron pulbere si solvent pentru solutie injectabila 80 mcg/0,5 ml
merck sharp&dohme limited - peginterferon alfa-2b - pulbere si solvent pentru solutie injectabila - 80 mcg/0,5 ml
ইউরোপীয় ইউনিয়ন -
রোমানীয় -
EMA (European Medicines Agency)
tecfidera
biogen netherlands b.v. - fumarat de dimetil - scleroză multiplă - imunosupresoare - tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
ইউরোপীয় ইউনিয়ন -
রোমানীয় -
EMA (European Medicines Agency)
dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - fumarat de dimetil - scleroză multiplă, scleroză multiplă recurent-remisivă - imunosupresoare - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
রুমানিয়া -
রোমানীয় -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
betaferon 250µg/ml
bayer ag - germania - interferonum beta 1b - pulb.+solv. pt. sol. inj. - 250µg/ml - imunostimulante interferoni
ইউরোপীয় ইউনিয়ন -
রোমানীয় -
EMA (European Medicines Agency)
alpheon
biopartners gmbh - recombinant human interferon alfa-2a - hepatita c, cronică - imunostimulante, - adult patients with histologically proven chronic hepatitis c who are positive for hepatitis c virus (hcv) antibodies or hcv rna and have elevated serum alanine aminotransferase (alt) without liver decompensation. the efficacy of interferon alfa-2a in the treatment of hepatitis c is enhanced when combined with ribavirin. alpheon should be given alone mainly in case of intolerance or contra-indication to ribavirin.
রুমানিয়া -
রোমানীয় -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
pegasys 180 microrgrame/0,5ml
roche pharma ag - germania - peginterferon alfa-2a - sol. inj. in seringa preumpluta - 180µg/0,5ml - imunostimulante interferoni
মোল্দাভিয়া -
রোমানীয় -
AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)
optipeg-a 180 180 mcg/0,5 ml soluţie injectabilă în seringă preumplută
incepta pharmaceuticals ltd. - peginterferon alfa-2a - soluţie injectabilă în seringă preumplută - 180 mcg/0,5 ml